NeuroMetrix will unveil and demonstrate Quell, a novel wearable pain relief device at the 2015 International Consumer Electronics show (CES) 6-9 January in Las Vegas, USA. NeuroMetrix will also be one of an exclusive group that will participate in CES Unveiled, the official press event of CES.
Quell utilises NeuroMetrix’s proprietary non-invasive neurostimulation technology to provide relief from chronic pain, such as due to diabetes, sciatica, fibromyalgia, and degenerative knee conditions. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. Users of the device will also have the option of using their smartphone to automatically track and personalize their pain therapy. The company expects Quell to be available for purchase by consumers in the second quarter of 2015.